1
|
Sun G, Sun X, Su H, Liao Y, Wei D, Ma H, Li X, Fan R, Ren X. RegionSizeR- A Novel App for Regional Sample Size Planning in MRCTs. Ther Innov Regul Sci 2024; 58:1071-1079. [PMID: 39117938 PMCID: PMC11530476 DOI: 10.1007/s43441-024-00679-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2024] [Accepted: 07/18/2024] [Indexed: 08/10/2024]
Abstract
In multi-regional clinical trials, planning the sample size for participating regions is essential for the evaluation of the treatment effect consistency across regions. Based on the MRCT design and sample size allocation to regions, consistency probability is usually used to predict the consistent trend between regions and the overall population, while preserving a certain proportion of the overall treatment effect. Specific enrollment characteristics in a region of interest should also be considered during the time of the sample size planning. To facilitate efficient and harmonized regional sample size planning, we have developed RegionSizeR, a comprehensive and user-friendly interactive web-based R shiny application that can be obtained from https://github.com/rsr-ss/RegionSizeR . This simulation-based app can serve as an initial point for discussions on sample size allocation plans, following preservation of treatment effect method in ICH E17. The app accommodates various types of endpoints and designs, including continuous, binary, and time-to-event endpoints, for superiority, non-inferiority, and MCP-Mod designs. To ensure the validity of this app, independent testing is conducted allowing a discrepancy of no more than 1% across all results considering various scenarios.
Collapse
Affiliation(s)
- Guannan Sun
- Pharmaceuticals Statistics and Data Insights, Bayer Healthcare Co. Ltd. Research & Development, 6F Parkview Green Blk B, No.9 Dongdaqiao Road, Beijing, China
| | - Xin Sun
- Pharmaceuticals Statistics and Data Insights, Bayer Healthcare Co. Ltd. Research & Development, 6F Parkview Green Blk B, No.9 Dongdaqiao Road, Beijing, China
| | - Huijuan Su
- Pharmaceuticals Statistics and Data Insights, Bayer Healthcare Co. Ltd. Research & Development, 6F Parkview Green Blk B, No.9 Dongdaqiao Road, Beijing, China
| | - Yuqin Liao
- Pharmaceuticals Statistics and Data Insights, Bayer Healthcare Co. Ltd. Research & Development, 6F Parkview Green Blk B, No.9 Dongdaqiao Road, Beijing, China
| | - Di Wei
- Pharmaceuticals Statistics and Data Insights, Bayer Healthcare Co. Ltd. Research & Development, 6F Parkview Green Blk B, No.9 Dongdaqiao Road, Beijing, China
| | - Hanqing Ma
- Pharmaceuticals Statistics and Data Insights, Bayer Healthcare Co. Ltd. Research & Development, 6F Parkview Green Blk B, No.9 Dongdaqiao Road, Beijing, China
| | | | - Ran Fan
- Akesobio Inc, Nanjing, China
| | - Xiaowei Ren
- Pharmaceuticals Statistics and Data Insights, Bayer Healthcare Co. Ltd. Research & Development, 6F Parkview Green Blk B, No.9 Dongdaqiao Road, Beijing, China.
| |
Collapse
|
2
|
Janitza S, Majumder M, Mendolia F, Jeske S, Kulmann H. Response to the Letter to the Editor by Koneswarakantha and Ménard. Ther Innov Regul Sci 2022; 56:379-380. [PMID: 35275362 DOI: 10.1007/s43441-022-00391-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2021] [Accepted: 03/03/2022] [Indexed: 10/18/2022]
Affiliation(s)
| | | | - Franco Mendolia
- Bayer AG, Research & Development, Pharmaceuticals, Statistics and Data Insights, 42113, Wuppertal, Germany.
| | | | | |
Collapse
|
3
|
Koneswarakantha B, Ménard T. Open Source Analytics App for Clinical Trials: Letter to the Editor-A Novel App for Insights into Laboratory Data of Clinical Trials. Ther Innov Regul Sci 2021; 55:1107-1108. [PMID: 34363199 DOI: 10.1007/s43441-021-00331-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2021] [Accepted: 07/30/2021] [Indexed: 11/28/2022]
|